Accelerate vaccine development with novel affinity purification solutions

Vaccine Insights 2024; 3(4), 279

DOI: 10.18609/vac.2024.025

Published: 5 August
FastFacts
Manuel Matos


Watch the video or view the poster to learn more about:

  • The importance of early vaccine candidate screening
  • Advantages of implementing affinity chromatography into the vaccine production process
  • Advantages of using CaptureSelect C-tagXL resin over other tag technologies



Manuel gained a PhD in Bioengineering Systems from MIT Portugal in 2021 where he developed artificial scaffolds for the affinity separation of biomolecules. Following his studies, Manuel has specialized in downstream processing development of antibodies, recombinant proteins, and viral vectors.